+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Progressive Supranuclear Palsy Therapeutics Market 2019-2023 - Product Image

Global Progressive Supranuclear Palsy Therapeutics Market 2019-2023

  • ID: 4771122
  • Report
  • Region: Global
  • 124 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.
  • MORE
About this market

The increasing strategic alliances are expected to trigger the progressive supranuclear palsy therapeutics market growth during the forecast period. Vendors in the market are entering into strategic alliances for co-developing and co-commercializing drugs of for licensing the drugs to large pharmaceutical vendors including the academic institutions and several small pharmaceutical vendors lacking the advanced manufacturing processes. The analysts have predicted that the progressive supranuclear palsy therapeutics market will register a CAGR of nearly 5% by 2023.

Market Overview

Increasing strategic alliances

The increasing strategic alliances are likely to result in the faster completion of the study leading to the quicker approval of the therapies, thus resulting in the growth of the global progressive supranuclear palsy therapeutics market during the forecast period.

Adverse side effects

The presence of strong adverse side effects of these drugs is currently a major challenge acting as a barrier to the market growth and is expected to remain a challenge to the growth of the global progressive supranuclear palsy therapeutics market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the progressive supranuclear palsy therapeutics market during 2019-2023, view the full report.

Competitive Landscape

The market appears to be highly concentrated and with the presence of a few market players. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Dopamine - Market size and forecast 2018-2023
  • Anticholinergic agents - Market size and forecast 2018-2023
  • Tricyclic antidepressants - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 16: About the Author


List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Global progressive supranuclear palsy therapeutics market pipeline: Overview
Exhibit 18: Global progressive supranuclear palsy therapeutics market pipeline: Snapshot
Exhibit 19: Product - Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Dopamine - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Dopamine - Year-over-year growth 2019-2023 (%)
Exhibit 23: Anticholinergic agents - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Anticholinergic agents - Year-over-year growth 2019-2023 (%)
Exhibit 25: Tricyclic antidepressants - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Tricyclic antidepressants - Year-over-year growth 2019-2023 (%)
Exhibit 27: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Others - Year-over-year growth 2019-2023 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in North America
Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Europe
Exhibit 39: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in Asia
Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 44: Top 3 countries in ROW
Exhibit 45: Key leading countries
Exhibit 46: Market opportunity
Exhibit 47: Global prevalence of geriatric population
Exhibit 48: Impact of drivers and challenges
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: AbbVie Inc. - Vendor overview
Exhibit 55: AbbVie Inc. - Business segments
Exhibit 56: AbbVie Inc. - Organizational developments
Exhibit 57: AbbVie Inc. - Geographic focus
Exhibit 58: AbbVie Inc. - Key offerings
Exhibit 59: AbbVie Inc. - Key customers
Exhibit 60: Acorda Therapeutics Inc. - Vendor overview
Exhibit 61: Acorda Therapeutics Inc. - Business segments
Exhibit 62: Acorda Therapeutics Inc. - Organizational developments
Exhibit 63: Acorda Therapeutics Inc. - Key offerings
Exhibit 64: Acorda Therapeutics Inc. - Key customers
Exhibit 65: Biogen Inc. - Vendor overview
Exhibit 66: Biogen Inc. - Business segments
Exhibit 67: Biogen Inc. - Organizational developments
Exhibit 68: Biogen Inc. - Geographic focus
Exhibit 69: Biogen Inc. - Key offerings
Exhibit 70: Biogen Inc. - Key customers
Exhibit 71: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 72: Bristol-Myers Squibb Co. - Business segments
Exhibit 73: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 74: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 75: Bristol-Myers Squibb Co. - Key offerings
Exhibit 76: Bristol-Myers Squibb Co. - Key customers
Exhibit 77: Merck & Co. Inc. - Vendor overview
Exhibit 78: Merck & Co. Inc. - Business segments
Exhibit 79: Merck & Co. Inc. - Organizational developments
Exhibit 80: Merck & Co. Inc. - Geographic focus
Exhibit 81: Merck & Co. Inc. - Segment focus
Exhibit 82: Merck & Co. Inc. - Key offerings
Exhibit 83: Merck & Co. Inc. - Key customers
Exhibit 84: Validation techniques employed for market sizing
Exhibit 85: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.
  • MORE
Global Progressive Supranuclear Palsy Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global progressive supranuclear palsy therapeutics market: AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., and Merck & Co. Inc.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the extensive research on the advent of gene therapy.”

According to the report, one of the major drivers for this market is the increasing awareness of progressive supranuclear palsy.

Further, the report states that one of the major factors hindering the growth of this market is the lack of approved therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Co.
  • Merck & Co. Inc.
Note: Product cover images may vary from those shown
Adroll
adroll